We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+10.98%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$40.7B
AUM Growth
-$4.56M
(-0.01%)
Cap. Flow
-$3.46B
Cap. Flow
% of AUM
-8.5%
Top 10 Holdings %
Top 10 Hldgs %
19.9%
Holding
801
New
88
Increased
169
Reduced
396
Closed
90
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$165M |
| 2 |
Costco
COST
|
+$134M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$126M |
| 4 |
Johnson Controls International
JCI
|
+$121M |
| 5 |
3M
MMM
|
+$112M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.48B |
| 2 |
Apple
AAPL
|
+$136M |
| 3 |
Marathon Petroleum
MPC
|
+$123M |
| 4 |
CenterPoint Energy
CNP
|
+$123M |
| 5 |
Under Armour
UAA
|
+$117M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.42% |
| 2 | Healthcare | 16.85% |
| 3 | Financials | 12.9% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Industrials | 10.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
JNPR
576
DELISTED
Juniper Networks
JNPR
| $7.18M | 0.02% |
291,500
-38,500
| -12% | -$947K |
|
|
SEE
577
DELISTED
Sealed Air
SEE
| $7.15M | 0.02% |
179,475
-8,500
| -5% | -$337K |
|
|
CALA
578
DELISTED
Calithera Biosciences, Inc
CALA
| $7.14M | 0.02% |
62,550
-2,450
| -4% | -$184K |
|
579
Globe Life
GL
$14.2B
| $7.03M | 0.02% |
66,800
-35,500
| -35% | -$3.54M |
|
580
Ralph Lauren
RL
$22.6B
| $6.97M | 0.02% |
+59,492
| New | +$6.27M |
|
|
GSKY
581
DELISTED
GreenSky, Inc. Class A Common Stock
GSKY
| $6.97M | 0.02% |
783,031
-18,225
| -2% | -$137K |
|
582
Rayonier Advanced Materials
RYAM
$604M
| $6.89M | 0.02% |
1,794,341
| – | – |
|
|
CTRA
583
DELISTED
Coterra Energy
CTRA
| $6.75M | 0.02% |
388,000
-22,600
| -6% | -$393K |
|
584
Quanta Services
PWR
$100B
| $6.65M | 0.02% |
163,347
-7,900
| -5% | -$322K |
|
585
Vale
VALE
$64.1B
| $6.6M | 0.02% |
500,000
-1,500,000
| -75% | -$18M |
|
586
Fox Class B
FOX
$21.8B
| $6.56M | 0.02% |
180,190
-9,000
| -5% | -$302K |
|
587
News Corp Class A
NWSA
$14.9B
| $6.29M | 0.02% |
444,970
-21,500
| -5% | -$289K |
|
588
Viatris
VTRS
$20.4B
| $6.24M | 0.02% |
310,571
-19,500
| -6% | -$363K |
|
589
Watts Water Technologies
WTS
$11.5B
| $6.23M | 0.02% |
+62,448
| New | +$5.93M |
|
590
Capri Holdings
CPRI
$1.83B
| $6.15M | 0.02% |
161,200
-8,400
| -5% | -$290K |
|
591
Royal Gold
RGLD
$16.8B
| $6.11M | 0.02% |
+50,000
| New | +$5.91M |
|
592
Warner Bros
WBD
$65.9B
| $6M | 0.01% |
183,430
-955,806
| -84% | -$28.8M |
|
593
Perrigo
PRGO
$1.4B
| $5.9M | 0.01% |
114,176
+8,250
| +8% | +$431K |
|
594
Aldeyra Therapeutics
ALDX
$92.9M
| $5.81M | 0.01% |
1,000,000
-418,822
| -30% | -$2.42M |
|
|
MRO
595
DELISTED
Marathon Oil Corporation
MRO
| $5.78M | 0.01% |
+425,800
| New | +$5.19M |
|
596
Kroger
KR
$35.4B
| $5.7M | 0.01% |
196,657
-763,065
| -80% | -$20.2M |
|
597
Rollins
ROL
$18.3B
| $5.65M | 0.01% |
255,750
-11,700
| -4% | -$277K |
|
|
ATRI
598
DELISTED
Atrion Corp
ATRI
| $5.64M | 0.01% |
7,500
-2,500
| -25% | -$1.89M |
|
599
FIVE9
FIVN
$2.11B
| $5.57M | 0.01% |
85,000
-15,000
| -15% | -$918K |
|
600
Ascendis Pharma A/S
ASND
$16B
| $5.57M | 0.01% |
40,000
-160,000
| -80% | -$17.8M |
|
Similar funds
Adage Capital Partners's Q4 2019 Portfolio in Review
As of Q4 2019, Adage Capital Partners held 801 positions worth $40.7B, down 0.01% from $40.7B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Adage Capital Partners withdrew a net $3.46B in Q4 2019, closing 90 positions and reducing 396 holdings. Its most notable exit was Celgene Corp, an estimated $1.48B position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Adage Capital Partners opened a new position in Bristol-Myers Squibb worth $142M.
- Adage Capital Partners's largest Q4 2019 buy was Bristol-Myers Squibb: 2,207,539 shares worth $142M.
- Adage Capital Partners added most to RTX Corp in Q4 2019, an estimated $165M increase.
- Adage Capital Partners's biggest Q4 2019 reduction was Apple, cutting an estimated $136M.
- Adage Capital Partners fully exited Celgene Corp in Q4 2019, selling an estimated $1.48B.
- Adage Capital Partners's ten largest holdings make up 20% of its $40.7B portfolio in Q4 2019.
- Adage Capital Partners opened 88 new positions and closed 90 in Q4 2019.
- Adage Capital Partners's portfolio value fell 0.01% quarter-over-quarter to $40.7B.
Based on Adage Capital Partners's 13F filing for Q4 2019, filed 14 Feb 2020.